| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.80B | 78.78B | 72.35B | 64.04B | 50.16B | 32.19B |
| Gross Profit | 45.39B | 48.38B | 44.80B | 39.80B | 30.11B | 17.62B |
| EBITDA | 19.10B | 20.29B | 19.10B | 16.83B | 11.42B | 4.10B |
| Net Income | 12.16B | 12.56B | 12.12B | 10.83B | 7.02B | 1.92B |
Balance Sheet | ||||||
| Total Assets | 48.31B | 60.14B | 51.98B | 46.51B | 36.95B | 27.47B |
| Cash, Cash Equivalents and Short-Term Investments | 22.95B | 32.20B | 26.08B | 23.69B | 17.16B | 9.91B |
| Total Debt | 541.00M | 0.00 | 300.00M | 307.02M | 450.69M | 734.00M |
| Total Liabilities | 10.86B | 12.20B | 11.89B | 11.29B | 10.44B | 7.11B |
| Stockholders Equity | 37.45B | 47.93B | 40.09B | 35.22B | 26.52B | 20.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.35B | 10.08B | 8.97B | 8.53B | 3.86B |
| Operating Cash Flow | 0.00 | 13.80B | 13.20B | 10.85B | 9.09B | 4.29B |
| Investing Cash Flow | 0.00 | -5.45B | -3.44B | -2.00B | -1.62B | -526.87M |
| Financing Cash Flow | 0.00 | -5.24B | -7.37B | -2.32B | -1.22B | -1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥324.54B | 25.64 | ― | 1.70% | 8.89% | 4.27% | |
73 Outperform | ¥69.96B | 11.90 | ― | 1.55% | 6.02% | 5.87% | |
65 Neutral | ¥204.85B | 11.75 | 13.33% | 3.47% | 3.37% | 5.12% | |
65 Neutral | ¥29.22B | 11.97 | ― | 1.23% | 5.09% | 10.97% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
50 Neutral | ¥41.47B | 41.94 | ― | 0.60% | 19.65% | 361.50% | |
49 Neutral | ¥60.47B | 47.32 | ― | 1.14% | 9.13% | -21.27% |